Trials / Completed
CompletedNCT00282997
A Safety Study Of Pregabalin In Fibromyalgia
A 12-Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 500 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety of pregabalin in patients with fibromyalgia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin |
Timeline
- Start date
- 2006-02-01
- Completion
- 2006-10-01
- First posted
- 2006-01-27
- Last updated
- 2021-01-22
Locations
72 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00282997. Inclusion in this directory is not an endorsement.